Thyroid cancer risk is not increased in diabetic patients.
OBJECTIVE: This study evaluated thyroid cancer risk with regards to diabetes status and diabetes duration, and with the use of anti-diabetic drugs including sulfonylurea, metformin, insulin, acarbose, pioglitazone and rosiglitazone, by using a population-based reimbursement database in Taiwan. METHO...
Main Author: | Chin-Hsiao Tseng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3531389?pdf=render |
Similar Items
-
Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.
by: Chin-Hsiao Tseng
Published: (2014-01-01) -
Diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study.
by: Chin-Hsiao Tseng
Published: (2014-01-01) -
Human insulin does not increase bladder cancer risk.
by: Chin-Hsiao Tseng
Published: (2014-01-01) -
Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus
by: Chin-Hsiao Tseng, et al.
Published: (2020-10-01) -
Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes
by: Chin-Hsiao Tseng, et al.
Published: (2020-10-01)